Dyspepsia: placebo vs antibiotic effect size
What is the placebo effect versus the antibiotic effect size in trials on the treatment of dyspepsia?
What is the placebo effect versus the antibiotic effect size in trials on the treatment of dyspepsia?
What would you recommend to your patients to reduce liver fibrosis?
Do noninvasive techniques for the diagnosis of liver fibrosis play a role in the treatment of liver disease?
Is Helicobacter pylori infection associated with a high risk of transmission to other persons or reinfection after successful treatment? Should family members of the patients be screened for H pylori infection?
What is the most common cause of gastrointestinal (GI) bleeding nowadays? Has the etiology of GI bleeding changed over the past decades?
Who should treat patients with cirrhosis? Can they be treated by a general practitioner, or perhaps specialist care is always necessary?
How do you perform fecal microbiota transplantation (FMT)? What is your experience with FMT in ulcerative colitis?
Are there any validated noninvasive diagnostic techniques that may be used for evaluation of liver fibrosis and cirrhosis?
Should the risk of developing antibiotic resistance prevent us from population screening for Helicobacter pylori?
Are there any factors that could delay liver fibrosis? Is coffee drinking beneficial?